ThursdayFeb 28, 2008 6:54 am

StockGuru Stocks to Watch for Thursday, February 28, 2008 Featuring GeoBio Energy, Utah Uranium, Automotive Software Designers, China America Holdings, and Copper King Mining

GeoBio Energy, Inc. (OTCBB: GBOE) GeoBio Energy, Inc. (OTCBB: GBOE) - Wednesday’s shares decreased 11.11% to $0.40. 28,270 shares were traded. GeoAlgae Technology, Inc.’s business is focused on three areas: 1) utilization of cost effective energy resources from identified geothermal locations for production of supply feedstock to the bio-diesel industry, 2) establishment of strategic alliances and acquisition of facilities for the production of bio-fuels, and 3) acquisition of established, profitable oil distribution industry companies positioned to achieve earnings within the first year of their acquisition and expand their profitability over the duration of an aggressive, five-year-plan. GeoBio Energy, Inc. is…

Continue Reading

ThursdayFeb 28, 2008 5:56 am

Beacon Equity Research Featured Company: Intelligentias, Inc. (ITLI.OB)

Intelligentias, Inc. (ITLI.OB) is a worldwide group of data intelligence Companies. The company markets Homeland Security products to Law Enforcement Agencies, telecommunication companies, Internet Service Providers and Enterprises all over the world. In response to the New York City terrorist attacks of 9-11 and the London and Madrid train bombings, many countries around the world are passing legislation that will require Telco's and ISP's to upgrade their existing infrastructures to capture, retain and manage telephone and internet surfing records. The aim of these directives is to enable Law Enforcement Agencies to quickly investigate and prosecute terrorists and serious crime activity.…

Continue Reading

ThursdayFeb 28, 2008 5:49 am

Small Cap Voice Featured Company: NextGen Bioscience, Inc. (NXGB.OB)

NextGen Bioscience, Inc. (NXGB.OB) is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of oncological and infectious diseases in human beings. The Company intends on becoming a world leader in the bioscience industry with the development and commercial licensure of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments. The company then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies. NextGen is rapidly building its portfolio of proprietary biotechnology. NextGen's target market,…

Continue Reading

ThursdayFeb 28, 2008 5:42 am

Beacon Equity Research Featured Company: NewMarket Technology, Inc. (NMKT.OB)

NewMarket Technology, Inc. (NMKT.OB) provides systems integration, emerging technology and technology infrastructure services throughout the world. The Company has combined a traditional systems integration and support services capacity with a specialized asset-based approach to assisting its clients with a delicate balance between maintaining legacy systems and gaining a competitive edge from the latest technology innovations. NewMarket provides certified integration and maintenance services to support the prevailing industry standard solutions. Their portfolio of services includes support for technologies from providers such as SAP, Oracle, Microsoft, Hyperion, BANN, Sun, Cisco, Siebel, SSA Global and iPass. NewMarket continuously seeks to acquire undiscovered emerging…

Continue Reading

ThursdayFeb 28, 2008 5:36 am

Beacon Equity Research Featured Company: Medistem Laboratories, Inc. (MDSM.OB)

Medistem Laboratories, Inc. (MDSM.OB) is an innovative biotechnology company committed to the creation and commercialization of advanced medical therapies based on non-controversial adult stem cells. Medistem's corporate mission is to transform these stem cells into valuable medical treatments. The Company's business strategy calls for the establishment of a series of clinics and laboratories around the world to deliver unprecedented, next-generation cell therapies to help millions of patients while seeking to commercialize products in the U.S. market. Medistem’s proprietary technology is based on adult stem cells sourced from umbilical cords, fat, bone marrow, and muscle, and is used Medistem’s licensee ICM…

Continue Reading

ThursdayFeb 28, 2008 5:31 am

Beacon Equity Research Featured Client: Axis Technologies, Inc. (AXTG.PK)

Axis Technologies, Inc. (AXTG.PK) is a subsidiary of Axis Technologies Group, Inc. The Company designs, manufactures, markets, and sells fluorescent lighting products for the commercial lighting industry in the United States and Canada. It offers a proprietary line of electronic dimming ballasts that regulate voltage in light fixtures. The company markets its products to commercial users of fluorescent lighting in office buildings, wholesale and retail buildings, hospitals, schools, and government buildings. Axis, dubbed “The Future of Fluorescent Lighting,” targets small to large commercial users of fluorescent lighting. This market includes office buildings, wholesale and retail buildings, hospitals, schools, and government…

Continue Reading

WednesdayFeb 27, 2008 7:22 pm

Edgeline Holdings, Inc. (ELHI.OB) Agrees to Terms for an Exclusive Worldwide Right to Option Patents Covering the Composition and Use of Genistein Analogs for Cancer Treatment

Edgeline Holdings, Inc. (ELHI.OB) Agrees to Terms for an Exclusive Worldwide Right to Option Patents Covering the Composition and Use of Genistein Analogs for Cancer Treatment Edgeline Holdings, Inc. (ELHI.OB), a biopharmaceutical company that engages in the discovery, development and commercialization of novel selective anticancer therapies, recently announced that the company has agreed to terms for an exclusive worldwide right to option patents covering the composition and use of Genistein analogs for cancer treatment. This technology was discovered and patented by the Pharmaceutical Research Institute of Warsaw Poland and involves compounds that appear to be novel antimicrotubule agents. Due to…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered